Iranian Journal of Allergy, Asthma and Immunology 2017. 16(5):425-432.

Frequency of Circulatory Regulatory Immune Cells in Iranian Patients with Type 1 Diabetes
Tahereh Khamehchian, Eqlim Nemati, Marziyeh Jazayeri, shirin Azimi, Hassan Nikoueinejad, Hossein Akbari, Behnaz Irandoust


Type 1 diabetes (T1D) is the result of the autoimmune destruction of insulin-producing beta cells. Regulatory T cells (Tregs) and plasmacytoid dendritic cells (PDCs) act as mediators of peripheral tolerance. We investigated the possible alterations of such cells in peripheral blood of patients with T1D compared to normal individuals. This comparison may lead to a better understanding of the immunopathogenesis processes involved in T1D. 92 participants, including 49 patients with T1D and 43 healthy controls were studied. 3 mL of blood was taken from all participants. After isolating peripheral blood mononuclear cells (PBMCs), PDCs as well as 2 subtypes of Tregs, CD4+CD25+FoxP3+ and CD8+CD28cells were counted by 3-colorflow cytometry. The association between such enumeration and T1D was studied by multivariate regression and discriminate function models. The frequency of CD4+CD25+FoxP3+Tregs (p=0.038) and PDCs (p=0.039) in the peripheral blood of diabetic patients was less than that in healthy subjects. Having compared some models consisting different cells as well as their combinations, we did not find any profound explanation of each subset or their combinations to identify T1D. The decrease of CD4+CD25+FoxP3+cells and PDCs in diabetic patients may suggest their role in the onset or development of the disease. Therefore, it is likely that their pharmacologic stimulation may direct immune responses towards tolerance and prevent the development or even the onset of diabetes in susceptible individuals.


CD4+CD25+FoxP3+regulatory T cells; CD8+CD28-regulatory T cells; Diabetes mellitus; Plasmacytoid dendritic cells

Full Text:



1. Rönnblom L, Pascual V. Thomas, Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther 2007; 9(4):219.

 2. Rönnblom L, Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 2008; 17(5):394-9.

3. Vogelsang P, Brun JG, Oijordsbakken G, Skarstein K, Jonsson R, Appel S. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome. Ann Rheum Dis 2010; 69(6):1235-8.
4. I. Pujol-Autonell et al., Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice. ISRN endocrinology 2013, 346987 (2013).
5. A. Wilkinson et al., Type 1 Diabetic Children and siblings share a decrease in dendritic cell and monocyte numbers but are differentiated by expansion of CD4+ T cells expressing IL-17. J Clin Cell Immunol S 2, (2011).

 6. Nieminen JK, Vakkila J, Salo HM, Ekström N, Härkönen T, Ilonen J, et al. Altered phenotype of peripheral blood dendritic cells in pediatric type 1 diabetes. Diabetes care 2012; 35(11):2303-10.

7. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011; 29:163-83.

 8. de Heer HJ, Hammad H, Soullié T, Hijdra D, Vos N, Willart MA, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200(1):89-98.

 9. Smit JJ, Bol-Schoenmakers M, Hassing I, Fiechter D, Boon L, Bleumink R, et al. The role of intestinal dendritic cells subsets in the establishment of food allergy. Clin Exp Allergy 2011; 41(6):890-8.

 10. Kavousanaki M, Makrigiannakis A, Boumpas D, Verginis P. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoidarthritis responding to therapy. Arthritis Rheum 2010;62(1):53-63.
11. Haeryfar SM. The importance of being a pDC in antiviralimmunity: the IFN mission versus Ag presentation?Trends Immunol 2005; 26(6):311-7.
12. Tisch R, Wang B. Role of plasmacytoid dendritic cells intype 1 diabetes: friend or foe? Diabetes 2009; 58(1):12-3.
13. Chen X, Makala LH, Jin Y, Hopkins D, Muir A, Garge N,et al., Type 1 diabetes patients have significantly lowerfrequency of plasmacytoid dendritic cells in theperipheral blood. Clin Immunol 2008; 129(3):413-8.
14. Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD.The countervailing actions of myeloid and plasmacytoiddendritic cells control autoimmune diabetes in thenonobese diabetic mouse. J Immunol 2007; 179, 5041-5053 (2007).
15. Montane J, Bischoff L, Soukhatcheva G, Dai DL,Hardenberg G, Levings MK, et al. Prevention of murineautoimmune diabetes by CCL22-mediated Tregrecruitment to the pancreatic islets. J Clin Invest 2011;121(8):3024-8.
16. Kouchaki E, Salehi M, Reza Sharif M, Nikoueinejad H,Akbari H. Numerical status of CD4(+)CD25(+)FoxP3(+)and CD8(+)CD28(-) regulatory T cells in multiplesclerosis. Iran J Basic Med Sci 2014; 17(4):250-5.
17. Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, ChiangBL. Inverse correlation between CD4+ regulatory T-cellpopulation and autoantibody levels in paediatric patientswith systemic lupus erythematosus. Immunology 2006;117(2):280-6.
18. Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H,Khajoee V, et al. CD25+CD4+ regulatory T cells inpatients with Kawasaki disease. J Pediatr 2004;145(3):385-90.
19. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T,Sawada T, et al. CD4+CD25bright T cells in humanintestinal lamina propria as regulatory cells. J Immunol2004; 173(5):3119-30.
20. Lawson CA, Brown AK, Bejarano V, Douglas SH,Burgoyne CH, Greenstein AS, et al., Early rheumatoidarthritis is associated with a deficit in the CD4+CD25highregulatory T cell population in peripheral blood.Rheumatology 2006; 45(10):1210-7.
21. Brusko TM, Wasserfall CH, Clare-Salzler MJ, SchatzDA, Atkinson MA. Functional defects and the influenceof age on the frequency of CD4+ CD25+ T-cells in type 1diabetes. Diabetes 2005; 54(5):1407-14.
22. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M,Tree TI. Defective suppressor function inCD4(+)CD25(+) T-cells from patients with type 1diabetes. Diabetes 2005; 54(1):92-9.
23. Putnam AL, Vendrame F, Dotta F, Gottlieb PA.CD4+CD25high regulatory T cells in human autoimmunediabetes. J Autoimmun 2005; 24(1):55-62.
24. Venken K, Hellings N, Hensen K, Rummens JL, MedaerR, D'hooghe MB, et al. Secondary progressive in contrastto relapsing-remitting multiple sclerosis patients show anormal CD4+CD25+ regulatory T-cell function andFOXP3 expression. J Neurosci Res 2006; 83(8):1432-46.
25. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+)regulatory T-cells in autoimmune liver disease. J Hepatol2004; 41(1):31-7.
26. Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmunediabetes. J Exp Med 2005; 202(10):1387-97.
27. Szypowska A, Stelmaszczyk-Emmel A, Demkow U,Luczyński W. Low frequency of regulatory T cells in theperipheral blood of children with type 1 diabetesdiagnosed under the age of five. Arch Immunol Ther Exp(Warsz) 2012; 60(4):307-13.
28. Luczyński W, Stasiak-Barmuta A, Urban R, Urban M,Florys B, Hryszko M. Lower percentages of T regulatorycells in children with type 1 diabetes - preliminary report.Pediatr Endocrinol Diabetes Metab 2009; 15(1):34-8.
29. Ryba-Stanisławowska M, Rybarczyk-Kapturska K,Myśliwiec M, Myśliwska J. Elevated levels of serum IL-
12 and IL-18 are associated with lower frequencies ofCD4(+)CD25 (high)FOXP3 (+) regulatory t cells inyoung patients with type 1 diabetes. Inflammation 2014;37(5):1513-20.
30. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X,Wang J, Serra P, et al. Reversal of autoimmunity byboosting memory-like autoregulatory T cells. Immunity2010; 32(4):568-80.
31. Hubert P, Jacobs N, Caberg JH, Boniver J, Delvenne P.The cross-talk between dendritic and regulatory T cells:good or evil? J Leukoc Biol 2007; 82(4):781-94.
32. Welzen-Coppens JM, van Helden-Meeuwsen CG, LeenenPJ, Drexhage HA, Versnel MA. The kinetics ofplasmacytoid dendritic cell accumulation in the pancreasof the NOD mouse during the early phases of insulitis.PloS one 2013; 8(1):e55071.
33. Lee MH, Lee WH, Todorov I, Liu CP. CD4+ CD25+regulatory T cells prevent type 1 diabetes preceded bydendritic cell-dominant invasive insulitis by affectingchemotaxis and local invasiveness of dendritic cells. JImmunol 2010; 185(4):2493-501.
34. Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PVCD4+CD25+ regulatory T cells control the progression
from periinsulitis to destructive insulitis in murineautoimmune diabetes. Cell Immunol 2005; 235(1):1-11.
35. Kayserova J, Vcelakova J, Stechova K, Dudkova E,Hromadkova H, Sumnik Z, et al. Decreased dendritic cellnumbers but increased TLR9-mediated interferon-alphaproduction in first degree relatives of type 1 diabetespatients. Clin Immunol 2014; 153(1):49-55.
36. Steptoe RJ, Ritchie JM, Harrison LC. Increasedgeneration of dendritic cells from myeloid progenitors inautoimmune-prone nonobese diabetic mice. J Immunol2002; 168(10):5032-41.
37. Vrabelova Z Hrotekova Z, Hladikova Z, Bohmova K,Stechova K, Michalek J. CD 127- and FoxP3+ expressionon CD25+CD4+ T regulatory cells upon specificdiabetogeneic stimulation in high-risk relatives of type 1diabetes mellitus patients. Scand J Immunol 2008;67(4):404-10.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.